Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury

Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas, United States of America.
PLoS ONE (Impact Factor: 3.23). 01/2013; 8(1):e53230. DOI: 10.1371/journal.pone.0053230
Source: PubMed


Developing new pharmacotherapies for traumatic brain injury (TBI) requires elucidation of the neuroprotective mechanisms of many structurally and functionally diverse compounds. To test our hypothesis that diverse neuroprotective drugs similarly affect common gene targets after TBI, we compared the effects of two drugs, metyrapone (MT) and carbenoxolone (CB), which, though used clinically for noncognitive conditions, improved learning and memory in rats and humans. Although structurally different, both MT and CB inhibit a common molecular target, 11β hydroxysteroid dehydrogenase type 1, which converts inactive cortisone to cortisol, thereby effectively reducing glucocorticoid levels. We examined injury-induced signaling pathways to determine how the effects of these two compounds correlate with pro-survival effects in surviving neurons of the injured rat hippocampus. We found that treatment of TBI rats with MT or CB acutely induced in hippocampal neurons transcriptional profiles that were remarkably similar (i.e., a coordinated attenuation of gene expression across multiple injury-induced cell signaling networks). We also found, to a lesser extent, a coordinated increase in cell survival signals. Analysis of injury-induced gene expression altered by MT and CB provided additional insight into the protective effects of each. Both drugs attenuated expression of genes in the apoptosis, death receptor and stress signaling pathways, as well as multiple genes in the oxidative phosphorylation pathway such as subunits of NADH dehydrogenase (Complex1), cytochrome c oxidase (Complex IV) and ATP synthase (Complex V). This suggests an overall inhibition of mitochondrial function. Complex 1 is the primary source of reactive oxygen species in the mitochondrial oxidative phosphorylation pathway, thus linking the protective effects of these drugs to a reduction in oxidative stress. The net effect of the drug-induced transcriptional changes observed here indicates that suppressing expression of potentially harmful genes, and also, surprisingly, reduced expression of pro-survival genes may be a hallmark of neuroprotective therapeutic effects.

Download full-text


Available from: Daniel Rodolfo Rojo, Mar 21, 2014
  • Source
    • "The possibility of an effective treatment could be based on the fact that the majority of traumatic neurodegeneration is due to a pathophysiological cascade after the injury that exacerbates the damaging effects of the injury. One of the validated mechanisms revealed in experimental traumatic brain injury involves oxygen radical-induced oxidative damage to lipids, proteins, and nucleic acids [3,5]. Developing new therapies for traumatic brain injury requires elucidation of the neuroprotective mechanisms [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Traumatic encephalopathy has emerged as a significant public health problem. It is believed that traumatic encephalopathy is caused by exposure to repetitive brain trauma prior to the initial symptoms of neurodegenerative disease. Therefore, prevention is important for the disease. The PI3K/AKT/PTEN (phosphoinositide-3 kinase/AKT/phosphatase and tensin homologue deleted on chromosome 10) pathway has been shown to play a pivotal role in neuroprotection, enhancing cell survival by stimulating cell proliferation and inhibiting apoptosis. PTEN negatively regulates the PI3K/AKT pathways through its lipid phosphatase activity. Although PTEN has been discovered as a tumor suppressor, PTEN is also involved in several other diseases, including diabetes and Alzheimer's disease. Dietary fish oil rich in polyunsaturated fatty acids may induce the PTEN expression by activation of peroxisome proliferator-activated receptor. Supplementation of these natural compounds may provide a new therapeutic approach to the brain disorder. We review recent studies on the features of several diets and the signaling pathways involved in traumatic encephalopathy.
    Alzheimer's Research and Therapy 09/2013; 5(5):42. DOI:10.1186/alzrt208 · 3.98 Impact Factor

  • World Neurosurgery 09/2013; 80(5). DOI:10.1016/j.wneu.2013.09.009 · 2.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glucocorticoid excess inhibits wound healing causing increased patient discomfort and infection risk. 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activates glucocorticoids (11-dehydrocorticosterone to corticosterone in rodents) in many tissues including skin, where de novo steroidogenesis from cholesterol has also been reported. To examine regulation of 11β-HSD1 and steroidogenic enzyme expression during wound healing, 5mm wounds were generated in female SKH1 mice and compared at days 0, 2, 4, 8, 14 and 21 relative to unwounded skin. 11β-HSD1 expression (mRNA and protein) and enzyme activity were elevated 2 and 4 days post-wounding with 11β-HSD1 localizing to infiltrating inflammatory cells. 11β-HSD2 (glucocorticoid-deactivating) expression and activity were undetectable. Although several steroidogenic enzymes displayed variable expression during healing, expression of the final enzyme required for conversion of 11-deoxycorticosterone to corticosterone, 11β-hydroxylase (CYP11B1) was lacking in unwounded skin and post-wounding. Consequently, 11-deoxycorticosterone was the principal progesterone metabolite in mouse skin before and after wounding. Our findings demonstrate that 11β-HSD1 activates considerably more corticosterone than generated de novo from progesterone in mouse skin and drives glucocorticoid exposure during healing, demonstrating the basis for 11β-HSD1 inhibitors to accelerate wound repair.
    Journal of Endocrinology 01/2014; 221(1). DOI:10.1530/JOE-13-0420 · 3.72 Impact Factor
Show more

Similar Publications